| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Former 10% Owner
2 companies
Omega Fund IV, L.P. last filed a Form 4 in March 2022, as 10% Owner at REPL. The filings on record cover 2 companies.
Our model assigns Omega Fund IV, L.P. a strong insider score of 81/100, based on 18 past trades. Over a 12-month horizon, 83.3% of those trades were profitable, with an average 12-month return of +32.4%.
At the last filing, the largest reported position was 4,673,380 shares of REPL. Net of sales, the REPL filings show accumulation of 66,170 shares.
Omega Fund IV, L.P. has 20 Form 4 filings on record from June 2018 to March 2022, across 2 companies: 10% Owner at Replimune Group (REPL), 2018–2022; Former 10% Owner at Kezar Life Sciences (KZR), 2018.
The 44 reported transactions were 30 open-market sales, 7 conversions, 4 option or other derivative awards and 2 open-market purchases, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $7.0M and 14 sales worth about $13.0M.
The largest open-market purchase was 266,667 shares of REPL at an average $15.00 on July 24, 2018, about $4.0M.
The largest open-market sale was 100,000 shares of REPL at an average $32.99 on September 17, 2021, about $3.3M. Twelve months later REPL was down 49%.
Shares as reported in the last Form 4 for each company; the most recent is from March 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2022 | REPL Replimune Group, Inc. | 10% Owner | Sale+OE | 106,500 | $15.55 | $1,656,482.88 | -2.2% | -8.4% | +23.6% | |
| Nov 22, 2021 | REPL Replimune Group, Inc. | Director, 10% Owner | Sell | 45,424 | $34.58 | $1,570,679.30 | -0.9% | -52.5% | -41.2% | |
| Nov 18, 2021 | REPL Replimune Group, Inc. | Director, 10% Owner | Sell | 2,594 | $33.50 | $86,899.00 | - | -47.5% | -43.1% | |
| Nov 18, 2021 | REPL Replimune Group, Inc. | Director, 10% Owner | Sell | 2,594 | $33.50 | $86,899.00 | - | -47.5% | -43.1% | |
| Nov 15, 2021 | REPL Replimune Group, Inc. | Director, 10% Owner | Sell | 24,017 | $33.66 | $808,412.22 | -0.5% | -48.7% | -40.4% | |
| Nov 11, 2021 | REPL Replimune Group, Inc. | Director, 10% Owner | Sell | 18,290 | $33.61 | $614,725.69 | -0.4% | -44.1% | -37.7% | |
| Nov 9, 2021 | REPL Replimune Group, Inc. | Director, 10% Owner | Sell | 11,354 | $33.66 | $382,207.02 | -0.2% | -43.5% | -46.2% | |
| Nov 5, 2021 | REPL Replimune Group, Inc. | Director, 10% Owner | Sell | 31,015 | $33.57 | $1,041,020.50 | -0.6% | -45.4% | -44.6% | |
| Sep 23, 2021 | REPL Replimune Group, Inc. | Director, 10% Owner | Sell | 12,171 | $33.58 | $408,702.18 | -0.2% | -17.0% | -52.8% | |
| Sep 17, 2021 | REPL Replimune Group, Inc. | Director, 10% Owner | Sell | 100,000 | $32.99 | $3,299,008.74 | -2.0% | -21.9% | -49.4% |